Thank you to all who joined us live Primary Care Pulse on February 23, 2021. If you were not able to join us live, the sessions have been recorded and are available below.
Upcoming Virtual Programs
Agenda
CME/CE Accredited Session
Non-CME/CE Session
Sponsored by Industry
Click For Session Details
Session Times Listed in ET
12-12:30PM ET CME/CE Accredited Session
Influenza: Your Questions Answered (February 2021)
Daniel A. Solomon, MD | Charles Vega, MD, FAAFP
Get your influenza questions answered during this live 30-minute Q&A session, hosted by primary care specialist Charles Vega, MD, FAAFP, and infectious disease specialist, Daniel Solomon, MD. The faculty will start the session with a brief discussion of a patient case and common questions they receive, followed by an open question and answer session from the audience for the remaining time.
Daniel A. Solomon, MD
Associate Physician, Division of Infectious Diseases, Brigham and Women's Hospital, Instructor of Medicine, Harvard Medical School, Boston, MA
Charles Vega, MD, FAAFP
Health Sciences Clinical Professor, UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education, Executive Director, UC Irvine Program in Medical Education for the Latino Community, UC Irvine School of Medicine, Irvine, CA
Supported by an educational grant from Genentech, a member of the Roche Group
12:40-1:25PM ET Non-CME Industry Theater
Primary Care Heart Failure Learning Module
Heart failure (HF) is a complex syndrome brought on by impairment of the structure or function of ventricular filling or blood ejection. These changes can significantly decrease quality of life, resulting in edema, dyspnea, and fatigue. The disease is widespread and progresses in severity, resulting in significant morbidity and mortality.
This course is built on the latest HF guidelines and seeks to help learners better understand this prevalent, serious disease. Topics include pathophysiology, etiology and epidemiology, morbidity and mortality, diagnosis through the use of biomarkers and other screening tools, impact of HF hospitalization, hospitalization care goals, and team-based care.
For more HF and cardiovascular disease education content, please see https://www.HallsofScience.com.
This content is developed exclusively by or on behalf of the industry sponsor; it is not reviewed or associated with Pri-Med and Pri-Med does not endorse or sanction any third-party content.
M-HFS-1397709 11/20
Sponsored by Novartis Pharmaceutical Corporation